Wall Street’s Key Stock Analysts Research Reports, All Buys
#stocks #bullish #buys #analysts #research #WallStreet
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Wednesday, 28 July, as follows:
AbbVie Inc. (NASDAQ:ABBV): Truist Securities resumed coverage of the pharmaceutical giant’s stock with a Buy rating and a 118 price target. The consensus target is at 124.08.
Bristol-Myers Squibb Co. (NYSE:BMY): Truist Securities resumed coverage with a Buy rating and a 74 price target. The consensus target is at 75.37.
Cummins Inc. (NYSE:CMI): The Vertical Research upgrade of the engine maker’s shares to Buy from Hold included a 280 price target. The consensus target is at 292.17.
Pfizer Inc. (NYSE:PFE): Trust Securities resumed coverage with a Buy rating and a 43 price target. The consensus target is at 43.32.
Weyerhaeuser Co. (NYSE:WY): The BofA Securities upgrade was from Neutral to Buy with a 41 price target. The consensus target is at 40.17.
Have a prosperous day, Keep the Faith!
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Larry Fink Called It. CME Just Made It Real. The Compute Futures Market Has Arrived
The Quantum-AI Convergence Is Real. The Quantum Stocks Aren't the Trade.
China’s Economic Resilience
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.